InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Lakefront Biotherapeutics NV

LKFT Clue Score73
Belgium CIK 0001421876
$29.73 +0.75% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $29.73 −40.19% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue129.5Operating income−11.5Net income54.0EPS, diluted1.14Fiscal year 2017Revenue127.1 −1.9%Operating income−89.8Net income−115.7 −314.2%EPS, diluted−2.34 −305.3%Fiscal year 2018Revenue278.7 +119.3%Operating income−47.1Net income−29.3EPS, diluted−0.56Fiscal year 2019Revenue834.9 +199.6%Operating income368.7Net income149.8EPS, diluted2.49Fiscal year 2020Revenue478.1 −42.7%Operating income−178.6Net income−305.4 −303.8%EPS, diluted−4.69 −288.4%Fiscal year 2021Revenue234.4 −51.0%Operating income−171.6Net income−103.2EPS, diluted−1.58Fiscal year 2022Revenue241.2 +2.9%Operating income−131.1Net income−218.0EPS, diluted−3.32Fiscal year 2023Revenue239.7 −0.6%Operating income−88.3Net income211.7EPS, diluted3.21Fiscal year 2024Revenue275.6 +15.0%Operating income−188.3Net income74.1 −65.0%EPS, diluted1.12 −65.1%Fiscal year 2025Revenue1,112.2 +303.5%Operating income295.0Net income320.9 +333.1%EPS, diluted4.87 +334.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 129.5 127.1 278.7 834.9 478.1 234.4 241.2 239.7 275.6 1,112.2
Growth −1.9% +119.3% +199.6% −42.7% −51.0% +2.9% −0.6% +15.0% +303.5%
Operating income −11.5 −89.8 −47.1 368.7 −178.6 −171.6 −131.1 −88.3 −188.3 295.0
Net income 54.0 −115.7 −29.3 149.8 −305.4 −103.2 −218.0 211.7 74.1 320.9
Growth −314.2% −303.8% −65.0% +333.1%
EPS, diluted 1.14 −2.34 −0.56 2.49 −4.69 −1.58 −3.32 3.21 1.12 4.87
Growth −305.3% −288.4% −65.1% +334.8%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−8.9%Net margin41.7%Free cash flow margin181.4%Fiscal year 2017Operating margin−70.7%Net margin−91.0%Free cash flow margin−119.9%Fiscal year 2018Operating margin−16.9%Net margin−10.5%Free cash flow margin−54.9%Fiscal year 2019Operating margin44.2%Net margin17.9%Free cash flow margin381.6%Fiscal year 2020Operating margin−37.4%Net margin−63.9%Free cash flow margin−98.3%Fiscal year 2021Operating margin−73.2%Net margin−44.0%Free cash flow margin−238.1%Fiscal year 2022Operating margin−54.3%Net margin−90.4%Free cash flow margin−218.8%Fiscal year 2023Operating margin−36.8%Net margin88.3%Free cash flow margin−177.2%Fiscal year 2024Operating margin−68.3%Net margin26.9%Free cash flow margin−122.2%Fiscal year 2025Operating margin26.5%Net margin28.9%Free cash flow margin−24.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −8.9% −70.7% −16.9% 44.2% −37.4% −73.2% −54.3% −36.8% −68.3% 26.5%
Net margin 41.7% −91.0% −10.5% 17.9% −63.9% −44.0% −90.4% 88.3% 26.9% 28.9%
Free cash flow margin 181.4% −119.9% −54.9% 381.6% −98.3% −238.1% −218.8% −177.2% −122.2% −24.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow239.4Capital expenditure−4.5Free cash flow234.9Fiscal year 2017Operating cash flow−147.0Capital expenditure−5.3Free cash flow−152.3 −164.8%Fiscal year 2018Operating cash flow−142.5Capital expenditure−10.4Free cash flow−152.9Fiscal year 2019Operating cash flow3,208.6Capital expenditure−22.4Free cash flow3,186.2Fiscal year 2020Operating cash flow−427.3Capital expenditure−42.5Free cash flow−469.9 −114.7%Fiscal year 2021Operating cash flow−503.8Capital expenditure−54.2Free cash flow−558.0Fiscal year 2022Operating cash flow−500.5Capital expenditure−27.4Free cash flow−527.9Fiscal year 2023Operating cash flow−406.0Capital expenditure−18.7Free cash flow−424.7Fiscal year 2024Operating cash flow−320.0Capital expenditure−16.7Free cash flow−336.7Fiscal year 2025Operating cash flow−257.5Capital expenditure−13.7Free cash flow−271.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 239.4 −147.0 −142.5 3,208.6 −427.3 −503.8 −500.5 −406.0 −320.0 −257.5
Capital expenditure −4.5 −5.3 −10.4 −22.4 −42.5 −54.2 −27.4 −18.7 −16.7 −13.7
Free cash flow 234.9 −152.3 −152.9 3,186.2 −469.9 −558.0 −527.9 −424.7 −336.7 −271.2
Growth −164.8% −114.7%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash973.2Shareholders’ equity758.7Fiscal year 2017Cash1,151.2Shareholders’ equity1,012.0Fiscal year 2018Cash1,290.8Shareholders’ equity1,214.2Fiscal year 2019Cash1,861.6Shareholders’ equity2,875.7Fiscal year 2020Cash2,135.2Shareholders’ equity2,670.4Fiscal year 2021Cash2,233.4Shareholders’ equity2,643.4Fiscal year 2022Cash508.1Shareholders’ equity2,526.0Fiscal year 2023Cash166.8Shareholders’ equity2,795.6Fiscal year 2024Cash64.2Shareholders’ equity2,896.9Fiscal year 2025Cash87.9Shareholders’ equity3,235.9
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 973.2 1,151.2 1,290.8 1,861.6 2,135.2 2,233.4 508.1 166.8 64.2 87.9
Shareholders’ equity 758.7 1,012.0 1,214.2 2,875.7 2,670.4 2,643.4 2,526.0 2,795.6 2,896.9 3,235.9

In millions of EUR, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of EUR, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
129.5 127.1 278.7 834.9 478.1 234.4 241.2 239.7 275.6 1,112.2
Growth −1.9% +119.3% +199.6% −42.7% −51.0% +2.9% −0.6% +15.0% +303.5%
n/a n/a n/a n/a n/a 1.6 12.1 n/a 34.9 29.7
139.6 218.5 316.2 420.1 523.7 320.5 269.8 241.3 335.5 459.4
21.7 24.4 34.4 72.4 118.8 127.7 135.2 128.3 117.2 147.3
−11.5 −89.8 −47.1 368.7 −178.6 −171.6 −131.1 −88.3 −188.3 295.0
Growth −148.4%
54.2 −115.5 −31.4 148.5 −309.8 −119.4 −70.8 5.6 −3.1 300.9
0.2 0.2 0.8 −0.2 1.2 1.4 0.6 9.6 −1.8 −18.6
54.0 −115.7 −29.3 149.8 −305.4 −103.2 −218.0 211.7 74.1 320.9
Growth −314.2% −303.8% −65.0% +333.1%
Per share
1.18 −2.34 −0.56 2.60 −4.69 −1.58 −3.32 3.21 1.12 4.87
1.14 −2.34 −0.56 2.49 −4.69 −1.58 −3.32 3.21 1.12 4.87
Growth −305.3% −288.4% −65.1% +334.8%
45.7 49.5 0.1 57.6 65.1 65.5 65.7 65.9 65.9 65.9
47.3 49.5 52.1 n/a n/a n/a 65.7 65.9 65.9 65.9
Growth +4.6% +5.3% +0.3% +0.0% +0.0%

Shown in EUR as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 18.4% a year over five years.
  • The diluted share count rose 33.2% in five years, which is dilution.
  • Operating margin is up 63.9 points on five years ago, at 26.5%.
  • A net loss in 5 of 10 years on file.